Log In
BCIQ
Print this Print this
 

ARC031

  Manage Alerts
Collapse Summary General Information
Company Archer Pharmaceuticals Inc.
DescriptionSoluble amyloid reducing agent
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today